)
)
)
450+
Decision-makers
They're all attending
){kind=logo}
Why Partner with the Life Science Legal Strategy Summit
)
Access Europe's Senior Life Science Legal Decision-Makers
Partnering with LSLS puts your brand in front of the people who matter most. With 50% of the audience made up of senior in-house counsel from pharma and biotech companies, including Chief Legal Officers, General Counsel, and Heads of IP, Regulatory and Competition Law, LSLS offers unrivalled access to the practitioners actively shaping life science legal strategy across Europe.
)
Build High-Quality Relationships That Last
With 10+ hours of dedicated networking built into the two-day programme, LSLS connects you with 450+ senior legal professionals, 50% of whom are in-house counsel. It is the ideal environment to forge meaningful connections and turn conversations into lasting commercial relationships.
)
Showcase Your Solutions Across the Full Legal Strategy Spectrum
LSLS is designed to move beyond theory into practical application. Partners can demonstrate how their solutions address real legal challenges, from UPC litigation and SPC strategy to EU Pharma Package compliance, competition scrutiny and M&A transactions, directly to senior decision-makers seeking proven tools they can implement immediately.
)
Position Your Brand as a Life Science Legal Thought Leader
LSLS is where the life science legal community comes to learn, benchmark and lead. Through keynote panels, expert roundtables, quick-fire presentations and innovative exhibition spaces, partners can share insights alongside private practitioners, regulators, patent offices, judges, and competition authorities. Partnering allows you to build credibility, demonstrate expertise and be part of the conversations driving the future of life science legal strategy.
A few words from our past sponsors
)
"Thoroughly enjoyed my first time at this summit! The topics for the panel discussions and roundtables were very interesting, and it was great to hear so many insights from both from innovators and generics, and their representatives."
)
"An outstanding conference for anyone navigating IP and regulatory exclusivity in the life science section. Highly valuable to legal professionals working both in-house and in private practice, and for originator and generics companies."
)
"The presentations and panel discussions are such that they bring you up to speed in the shortest possible time and at the highest level. Combined with the opportunity to exchange ideas with colleagues, clients, and representatives of various offices in a pleasant atmosphere, this seminar is a highlight for me every year."
)
"Another great event. The place to be if you want to get the latest developments on all things Life Science!"
)
)
){kind=logo}
)
){kind=logo}
)
){kind=logo}
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
)